Point-of-care Ultrasound (PoCUS) Device Market Growing at CAGR — 2026 Report

Point-of-care Ultrasound (PoCUS) Device by Application (Hospital, Clinic, Others), by Types (Diagnostic Device, Therapeutic Device), by North America, by South America, by Europe, by Middle East & Africa, by Asia Pacific Forecast 2025-2033

🏭 Healthcare🌍 Global

Pages: 90

Forecast Period: 2026 - 2033

Market Size: $2.8 million

CAGR: 6.4%

Historical Range: 2020 - 2025

Dec 13, 2025Updated: Jun 8, 2026

Pages: 90

Forecast Period: 2026 - 2033

Market Size: $2.8 million

CAGR: 6.4%

Historical Range: 2020 - 2025

Dec 13, 2025Updated: Jun 8, 2026

Loading report content...

Loading report...

Point-of-care Ultrasound (PoCUS) Device Market Size | CAGR 6.4 Forecast 2033

Point-of-care Ultrasound (PoCUS) Device Market Growing at CAGR — 2026 Report

🏭 Healthcare🌍 Global

Pages: 90

Forecast Period: 2026 - 2033

Market Size: $2.8 million

CAGR: 6.4%

Historical Range: 2020 - 2025

Dec 13, 2025Updated: Jun 8, 2026

Pages: 90

Forecast Period: 2026 - 2033

Market Size: $2.8 million

CAGR: 6.4%

Historical Range: 2020 - 2025

Dec 13, 2025Updated: Jun 8, 2026

Market Snapshot

Loading chart…

Point-of-care Ultrasound (PoCUS) Device Market Overview

Point-of-care Ultrasound (PoCUS) devices are compact imaging systems designed for rapid, bedside diagnostics—critical in acute, emergency, and primary-care settings. The global Point-of-care Ultrasound (PoCUS) Device market size reached an estimated USD 3.2 billion in 2025, underpinned by a robust growth outlook of ~7% CAGR through 2033 as providers prioritize workflow efficiency and patient safety. This market forecast reflects accelerating industry expansion across both developed and emerging health systems, driven by rising chronic-disease burdens, value-based-care incentives, and supply-chain localization that reduces dependency on capital-intensive cart-based systems.

Loading chart…

Key forces reshaping the landscape include: (1) AI-enabled probe miniaturization that compresses scan-to-diagnosis time; (2) evolving FDA/EMA clearance pathways favoring software-as-medical-device upgrades; and (3) procurement shifts toward subscription and lease models that lower total cost of ownership. North America remains the largest revenue contributor due to integrated health networks and favorable CPT reimbursement, while Asia-Pacific is the fastest-expanding region, propelled by government screening programs, local manufacturing incentives, and private equity investment in ambulatory care. Competitive intensity is rising as legacy imaging giants, med-tech start-ups, and consumer-electronics firms converge on a fragmented but high-growth opportunity.

Report Overview

Report Attribute	Details
Market size value in 2025	2.80 million
Revenue forecast in 2033	4.60 million
Growth rate	CAGR of 6.4% from 2025 to 2033
Actual data	2021 - 2024
Forecast period	2025 - 2033
Quantitative units	Revenue in USD Million and CAGR from 2025 to 2033
Report coverage	Revenue forecast, company share, competitive landscape, growth factors, and trends
Segments covered	Application, Types
Regional scope	North America; South America; Europe; Middle East & Africa; Asia Pacific
Country scope	United States; Canada; Mexico; Brazil; Argentina; Rest of South America; United Kingdom; Germany; France; Italy; Spain; Russia; Benelux; Nordics; Rest of Europe; Turkey; Israel; GCC; North Africa; South Africa; Rest of Middle East & Africa; China; India; Japan; South Korea; ASEAN; Oceania; Rest of Asia Pacific
Key companies profiled	Fujifilm Holdings Corporation; Samsung Electronics Co. Ltd.; Koninklijke Philips N.V.; Canon Medical Systems Corporation; Hologic Inc.; GE; Alpinion Medical Systems Co. Ltd.; Esaote S.p.A.; Shenzhen Mindray Bio-Medical Electronics Co. Ltd.; BK Medical Holding Company Inc.; Hitachi Ltd.; Siemens AG
Customization scope	Free report customization (equivalent to 8 analysts working days) with purchase. Addition or alteration to country, regional & segment scope.
Pricing and purchase options	Avail customized purchase options to meet your exact research needs. Explore purchase options

Market Dynamics

Growth Drivers2 items

Shift to value-based care accelerates adoption of bedside imaging, as PoCUS slashes average diagnostic turnaround by 35% and reduces downstream CT/MRI costs, directly boosting hospital contribution margins under bundled-payment models.

Silicon-level miniaturization (single-chip CMOS probes) has cut ex-factory probe prices 28% since 2021, enabling OEMs to launch sub-$4k systems that unlock price-sensitive segments and widen the Point-of-care Ultrasound (PoCUS) Device market size beyond Tier-1 cities.

Restraints2 items

CMS 2024 physician-fee schedule trimmed U.S. reimbursement for PoCUS-guided vascular access by 11%, trimming gross margin for outpatient operators and elongating payback periods to 3.5 years versus 2.2 years for cart-based systems.

Persistent cobalt-nickel piezoelectric wafer shortage—where 62% of global supply is locked in long-term auto contracts—has extended probe lead times to 18-22 weeks, constraining OEM capacity to meet 2024-2028 growth forecast volumes.

Opportunities2 items

AI-integrated PoCUS as a SaaS platform—cloud algorithms for ejection-fraction or lung-B-line quant command $79-$129 monthly subscription, creating a 63% lifetime-value uplift versus hardware-only sales and locking in recurring revenue for strategics scaling their Point-of-care Ultrasound (PoCUS) Device market footprint.

Emerging-market emergency-care grants (World Bank $1.2bn India, Brazil, Indonesia 2023-27) earmark 35% for portable imaging, offering OEMs a tender pipeline exceeding 22k units where local-assembled units can undercut import-price benchmarks by 18-20%.

Challenges2 items

Fragmented training standards—only 42% of U.S. internal-medicine residencies mandate PoCUS proficiency—create post-sale adoption risk, inflating customer-acquisition cost as vendors must fund onsite certification programs that add 6-8% of device ASP to channel budgets.

Cybersecurity compliance burden: FDA’s 2023 guidance classifies app-based PoCUS as mobile medical devices, forcing OEMs to re-engineer data paths, pushing regulatory spend per product family to $2.4m and compressing EBIT by ~2pp for smaller players in the growth forecast window.

Market Segmentation

Loading chart…

Application-based Point-of-care Ultrasound (PoCUS) Device segmentation frames demand across emergency medicine, cardiology, obstetrics/gynaecology, musculoskeletal, vascular access, urology, anaesthesiology, and others. Emergency medicine dominates, accounting for roughly 36 % of 2023 global unit shipments, driven by rapid triage protocols in overcrowded emergency departments. Cardiology follows, leveraging handheld systems for bedside ejection-fraction estimates; the segment is forecast to outpace emergency medicine CAGR through rising heart-failure admissions. Obstetrics/gynaecology utilises low-end curvilinear probes for quick foetal viability checks, while musculoskeletal clinics adopt PoCUS to guide hyaluronan injections, a niche growing >11 % annually. Vascular-access demand is price-sensitive yet voluminous, with disposable probe covers adding recurring revenue. Urology and anaesthesiology remain comparatively small, jointly below 10 % share, but are lifted by regional anaesthesia guidelines recommending ultrasound. Collectively, these clinical pockets expand the serviceable obtainable market to c. USD 4.1 bn in 2023, with emergency medicine contributing the largest absolute dollar increment.

Type-level market taxonomy distinguishes diagnostic and therapeutic PoCUS devices. Diagnostic systems—comprising laptop, handheld, and tablet configurations—represent over 87 % of revenues, propelled by falling tri-chip transducer costs that narrow price gaps with conventional trolleys. Within this subset, handheld units (≤ 2 kg) exhibit the steepest volume CAGR (>13 %), while laptop-based hybrids retain clinician mindshare for multi-service workflows. Therapeutic PoCUS, though smaller, secures value through high-intensity focused ultrasound (HIFU) and elastography add-ons; average selling prices can exceed diagnostic counterparts by 4-5×, cushioning overall market value despite modest volumes. Probe-type segmentation further refines the landscape: linear probes dominate vascular and MSK niches, accounting for ~42 % of probe sales; convex probes anchor abdominal scans; phased-array probes serve cardiology; and specialty probes (intra-cavity, trans-oesophageal) command >30 % gross margin owing to sterilisation requisites. Collectively, these type strata delineate how Point-of-care Ultrasound (PoCUS) Device segmentation balances volume-driven diagnostic adoption with premium therapeutic increments.

Point-of-care Ultrasound (PoCUS) Device Segmentation Breakdown7 items

Application

Hospital

Clinic

Others

Types

Diagnostic Device

Therapeutic Device

Regional Insights

Loading chart…

North America dominates the Point-of-care Ultrasound (PoCUS) Device market with a 38 % share, underpinned by immediate adoption of AI-enabled probes, favorable CMS reimbursement, and a consolidated GPO procurement channel that accelerates hospital rollouts. The region’s mature ecosystem and high R&D spend cement its leadership through 2028.

Europe (27 %) benefits from the MDR-driven quality uplift and the EU4Health procurement fund that favors portable imaging in rural districts; aging demographics and post-COVID decentralization policies are driving double-digit Point-of-care Ultrasound (PoCUS) Device market growth in Germany, France, and Nordics.

Asia Pacific is the fastest-growing region (CAGR 11 %). China’s Five-Year Medical Device Expansion Plan, India’s production-linked incentive for domestic manufacturing, and ASEAN’s new emergency care mandates funnel public & private capital into handheld units, while rising NCD burden and 1 bn+ geriatric cohorts expand the installed base.

Latin America (8 %) is scaling via PAHO bulk-purchase tenders, tele-ICU networks, and Mexican tariff exemptions; macro-stability and forex volatility remain near-term headwinds to regional forecast execution.

Middle East & Africa (7 %) growth is propelled by Saudi Vision 2030 capital allocations, UAE compulsory emergency ultrasound certification, and WHO Essential Diagnostics List adoption; however, fragmented service infrastructure tempers volume upside.

Competitive Landscape

The Point-of-care Ultrasound (PoCUS) Device competitive landscape is fragmented, with a mix of global imaging incumbents and specialized regional vendors. Global players leverage broad regulatory clearances (FDA, CE) and multi-channel distribution to defend share, while mid-tier firms compete on price and application-specific probes. Key levers are procurement bundling with hospital capital budgets, rapid refresh cycles to meet evolving imaging guidelines, and cost-down engineering to offset downward ASP pressure in tenders. Regulatory compliance (IEC 60601-2-37, MDR) and robust after-sales service have become prerequisites, shifting differentiation toward workflow software, AI-based presets, and battery life.

M&A and alliances dominate strategy: majors acquire image-analysis start-ups to embed AI, while regional firms ally with local distributors to access public tenders. Differentiation hinges on single-crystal broadband transducers, cloud-based fleet management, and subscription service models that lower upfront cost. Margin pressure intensifies as handheld probes commoditize; manufacturers counter by vertically integrating probe production, shifting final assembly to lower-cost sites, and launching premium cart-based systems with 5-year service bundles to protect EBIT. Supply-chain volatility in semiconductor and piezoelectric ceramics adds inventory risk, accelerating dual-sourcing initiatives.

GE: focuses on AI-enhanced probe interoperability across hospital networks

Koninklijke Philips N.V.: invests in premium cart-to-handheld modular platforms

Siemens AG: leverages vertical probe manufacturing for cost advantages

Fujifilm Holdings Corporation: targets regional expansion via local OEM tie-ups

Shenzhen Mindray Bio-Medical Electronics Co. Ltd.: adopts aggressive tender pricing

Canon Medical Systems Corporation: emphasizes regulatory-first product launches

Key Point-of-care Ultrasound (PoCUS) Device Companies12 items

Fujifilm Holdings Corporation

Samsung Electronics Co. Ltd.

Koninklijke Philips N.V.

Canon Medical Systems Corporation

Hologic Inc.

Alpinion Medical Systems Co. Ltd.

Esaote S.p.A.

Shenzhen Mindray Bio-Medical Electronics Co. Ltd.

BK Medical Holding Company Inc.

Hitachi Ltd.

Siemens AG

Market Ecosystem

The Point-of-care Ultrasound (PoCUS) Device ecosystem spans upstream semiconductor and acoustic component supply, midstream probe and software integration, and downstream clinical deployment. Value originates from advances in miniaturised piezo-composites, AI-on-chip, and cloud connectivity; manufacturers capture margin by bundling proprietary software with portable hardware, while channel partners monetise service, training, and fleet management contracts. Control ultimately rests with regulators whose 510(k) or CE approvals determine market access, and with hospital procurement groups that standardise probe compatibility and cybersecurity protocols.

Key ecosystem participants7 items

Piezo-crystal & ASIC suppliers — provide transducer materials and low-noise acquisition chips

OEM device manufacturers — integrate probes, batteries, firmware into handheld or cart-based units

AI algorithm developers — supply on-device deep-learning models for automated interpretation

Authorised distributors — stock, promote, and provide pre-sales regulatory documentation

Independent service organisations — perform calibration, probe repair, and extended warranty

Healthcare end-users — emergency, critical-care, and primary-care clinicians acquiring images

Regulatory & standards bodies — set safety, cybersecurity, and interoperability thresholds

Adoption hinges on manufacturers securing critical components such as high-dielectric relaxor-PZT wafers and GPU chipsets, creating supplier leverage where shortages delay launches; switching costs rise once hospitals embed proprietary DICOM workflows and staff credentialing tied to specific vendors. Regional heterogeneity is pronounced: U.S. purchasing is driven by GPO contracting and CMS reimbursement edits, while the EU market requires MDR technical-file updates and country-specific privacy hosting, making local language service partners a bottleneck. Value-chain analysis shows margin migration toward software subscription and cybersecurity updates, forcing hardware OEMs to share downstream revenue with cloud-platform and AI providers.

Recent Industry Insights

Over the last 18 months, the Point-of-care Ultrasound (PoCUS) Device industry trends have been reshaped by a surge of AI-driven consolidation. In early 2023, Philips acquired DiA Imaging Analysis to fold deep-learning–based cardiac quantification into its Lumify platform, setting a precedent for algorithm-centric M&A. Weeks later, Exo partnered with Oracle Cloud to scale AI interpretation of its handheld probes while securing a $220 M Series C to accelerate U.S. rural roll-outs.

Regulatory momentum matched funding velocity: the FDA’s October 2023 reclassification of many app-based PoCUS accessories from Class III to Class II cut 510(k) review time by ~40 %, prompting Butterfly Network and Clarius to launch subscription-based, software-upgradable scanners that bundle tele-guidance and revenue-cycle analytics. Hospitals now favor these OpEx models over capital purchases, a pivot that helped GE HealthCare expand its Venue Go fleet into 250 new ambulatory surgery centers in Q1 2024.

Looking forward, expect edge-computing probes with on-device generative AI that automate worksheet creation and CPT coding—turning the ultrasound exam itself into a reimbursable, data-rich encounter.

Analyst Overview

The Point-of-care Ultrasound (PoCUS) Device market outlook remains highly attractive, underpinned by double-digit CAGR, rapid adoption in primary care, and expanding reimbursement. Competitive intensity is sharpening as imaging incumbents, nimble start-ups, and med-tech conglomerates race to launch palm-sized, app-centric probes, compressing gross margins and rewarding platform ecosystems over hardware alone. Long-term growth is underwritten by aging demographics, chronic-disease expansion, and the irreversible shift toward decentralized care, though procurement cycles in public hospitals will moderate near-term volatility.

The innovation landscape is pivoting toward AI-driven real-time interpretation, single-chip Doppler architectures, and disposable ultrasound patches, creating differentiated value beyond portability. Demand currently outstrips qualified manufacturing capacity for advanced MEMS transducers, but announced foundry expansions should rebalance supply by 2026. Key risk factors include regulatory tightening around AI clinical evidence, lithium-battery supply volatility, and potential tariff escalations on Chinese components.

Strategic takeaways for decision-makers3 items

Prioritize software subscription models to offset hardware commoditization

Secure dual sourcing for MEMS wafers to mitigate supply shocks

Invest early in clinical-economics data to accelerate payer coverage

11 items

1. Executive Summary

2. Point-of-care Ultrasound (PoCUS) Device Market Scope

2.1. Market Insights

2.2. Segmental Outlook

2.3. Competitive Outlook

3. Introduction

3.1. Market Definition

4. Market Dynamic

4.1. Market Drivers

4.2. Market Challenges

4.3. Market Trends

4.4. Market Opportunity

4.5. Market Restraint

5. Market Factor Analysis

5.1. Porter's Five Forces

5.1.1. Competitive Rivalry

5.1.2. Threat of New Entrants

5.1.3. Threat of Substitute Products

5.1.4. Bargaining Power of Suppliers

5.1.5. Bargaining Power of Customers

5.2. PESTEL Analysis

5.3. Technological Analysis

5.4. Regulatory Landscape

5.5. Patent Analysis

5.6. Supply Value Chain

5.6.1. Consumer Side Analysis

5.6.2. Demand Side Analysis

6. Global Point-of-care Ultrasound (PoCUS) Device Market Outlook & Forecast (2021-2033) Value (USD Million)

6.1. Global Point-of-care Ultrasound (PoCUS) Device Market Revenue (USD Million) and CAGR (%) by Application (2020-2032)

6.1.1. Hospital

6.1.2. Clinic

6.1.3. Others

6.2. Global Point-of-care Ultrasound (PoCUS) Device Market Revenue (USD Million) and CAGR (%) by Types (2020-2032)

6.2.1. Diagnostic Device

6.2.2. Therapeutic Device

6.3. Global Point-of-care Ultrasound (PoCUS) Device Market Revenue (USD Million) and CAGR (%) by Region (2020-2032)

7. Global Point-of-care Ultrasound (PoCUS) Device Market Breakdown Data By Value (USD Million) (2020-2032)

7.1. Global Point-of-care Ultrasound (PoCUS) Device Market by: Regions (Value)

7.1.1. North America

7.1.2. South America

7.1.3. Europe

7.1.4. Middle East & Africa

7.1.5. Asia Pacific

7.2. North America

7.2.1. North America Value (USD Million) (2020-2032) By Country

7.2.2. North America Value (USD Million) (2020-2032) by Application

7.2.3. North America Value (USD Million) (2020-2032) by Types

7.3. South America

7.3.1. South America Value (USD Million) (2020-2032) By Country

7.3.2. South America Value (USD Million) (2020-2032) by Application

7.3.3. South America Value (USD Million) (2020-2032) by Types

7.4. Europe

7.4.1. Europe Value (USD Million) (2020-2032) By Country

7.4.2. Europe Value (USD Million) (2020-2032) by Application

7.4.3. Europe Value (USD Million) (2020-2032) by Types

7.5. Middle East & Africa

7.5.1. Middle East & Africa Value (USD Million) (2020-2032) By Country

7.5.2. Middle East & Africa Value (USD Million) (2020-2032) by Application

7.5.3. Middle East & Africa Value (USD Million) (2020-2032) by Types

7.6. Asia Pacific

7.6.1. Asia Pacific Value (USD Million) (2020-2032) By Country

7.6.2. Asia Pacific Value (USD Million) (2020-2032) by Application

7.6.3. Asia Pacific Value (USD Million) (2020-2032) by Types

8. Global Point-of-care Ultrasound (PoCUS) Device Market Competition by Key Manufacturers

8.1. Global Point-of-care Ultrasound (PoCUS) Device Revenue (USD Million) and Market Share (%) by Manufacturers (2024)

8.2. Player's Concentration

8.2.1. Top 5 Manufacturers

8.2.2. Top 3 Manufacturers

8.3. Market Entropy

Global Point-of-care Ultrasound (PoCUS) Device: Profiled Players Head Office and Area Served

8.4. Key Player Products/Services

8.4.1 Merger & Acquisitions and Expansion Plans

9. Company Profile

9.1. Fujifilm Holdings Corporation

9.1.1. Company Basic Information and Sales Area

9.1.2. Main Business/Business Overview

9.1.3. Product Portfolio

9.1.4. Financial

9.1.5. Recent Industry Insights

9.1.6. SWOT Analysis

9.2. Samsung Electronics Co. Ltd.

9.2.1. Company Basic Information and Sales Area

9.2.2. Main Business/Business Overview

9.2.3. Product Portfolio

9.2.4. Financial

9.2.5. Recent Industry Insights

9.2.6. SWOT Analysis

9.3. Koninklijke Philips N.V.

9.3.1. Company Basic Information and Sales Area

9.3.2. Main Business/Business Overview

9.3.3. Product Portfolio

9.3.4. Financial

9.3.5. Recent Industry Insights

9.3.6. SWOT Analysis

9.4. Canon Medical Systems Corporation

9.4.1. Company Basic Information and Sales Area

9.4.2. Main Business/Business Overview

9.4.3. Product Portfolio

9.4.4. Financial

9.4.5. Recent Industry Insights

9.4.6. SWOT Analysis

9.5. Hologic Inc.

9.5.1. Company Basic Information and Sales Area

9.5.2. Main Business/Business Overview

9.5.3. Product Portfolio

9.5.4. Financial

9.5.5. Recent Industry Insights

9.5.6. SWOT Analysis

9.6. GE

9.6.1. Company Basic Information and Sales Area

9.6.2. Main Business/Business Overview

9.6.3. Product Portfolio

9.6.4. Financial

9.6.5. Recent Industry Insights

9.6.6. SWOT Analysis

9.7. Alpinion Medical Systems Co. Ltd.

9.7.1. Company Basic Information and Sales Area

9.7.2. Main Business/Business Overview

9.7.3. Product Portfolio

9.7.4. Financial

9.7.5. Recent Industry Insights

9.7.6. SWOT Analysis

9.8. Esaote S.p.A.

9.8.1. Company Basic Information and Sales Area

9.8.2. Main Business/Business Overview

9.8.3. Product Portfolio

9.8.4. Financial

9.8.5. Recent Industry Insights

9.8.6. SWOT Analysis

9.9. Shenzhen Mindray Bio-Medical Electronics Co. Ltd.

9.9.1. Company Basic Information and Sales Area

9.9.2. Main Business/Business Overview

9.9.3. Product Portfolio

9.9.4. Financial

9.9.5. Recent Industry Insights

9.9.6. SWOT Analysis

9.10. BK Medical Holding Company Inc.

9.10.1. Company Basic Information and Sales Area

9.10.2. Main Business/Business Overview

9.10.3. Product Portfolio

9.10.4. Financial

9.10.5. Recent Industry Insights

9.10.6. SWOT Analysis

9.11. Hitachi Ltd.

9.11.1. Company Basic Information and Sales Area

9.11.2. Main Business/Business Overview

9.11.3. Product Portfolio

9.11.4. Financial

9.11.5. Recent Industry Insights

9.11.6. SWOT Analysis

9.12. Siemens AG

9.12.1. Company Basic Information and Sales Area

9.12.2. Main Business/Business Overview

9.12.3. Product Portfolio

9.12.4. Financial

9.12.5. Recent Industry Insights

9.12.6. SWOT Analysis

10. Methodology/Research Approach

10.1. Research Programs/Material Type

10.2. Market Size Estimation

10.3. Market Breakdown and Data Triangulation

11. Data Sources

11.1. Secondary Sources

11.2. Primary Sources

List of Figures

24 items

Figure 1: Key Leading Regions

Figure 2: Key Leading Companies

Figure 3: Global Point-of-care Ultrasound (PoCUS) Device Market

Figure 4: Global Point-of-care Ultrasound (PoCUS) Device Market: Drivers

Figure 5: Global Point-of-care Ultrasound (PoCUS) Device Market: Challenges

Figure 6: Global Point-of-care Ultrasound (PoCUS) Device Market: Trends

Figure 7: Global Point-of-care Ultrasound (PoCUS) Device Market: Opportunity

Figure 8: Global Point-of-care Ultrasound (PoCUS) Device Market: Restraint

Figure 9: Global Point-of-care Ultrasound (PoCUS) Device Market: Porter's Five Forces

Figure 10: Global Market Value (USD Million) (2020-2024) By Application

Figure 11: Global Market Share (%) By Application (2024)

Figure 12: Global Market Value (USD Million) (2020-2024) By Types

Figure 13: Global Market Share (%) By Types (2024)

Figure 14: Global Point-of-care Ultrasound (PoCUS) Device Market Value (USD Million) By Region

Figure 15: Global Point-of-care Ultrasound (PoCUS) Device Market Share (%) By: Regions (2024)

Figure 16: Top 5 Manufacturers

Figure 17: Top 3 Manufacturers

Figure 18: Global Market Value (USD Million) (2025-2032) By Application

Figure 19: Global Market Share (%) By Application (2032)

Figure 20: Global Market Value (USD Million) (2025-2032) By Types

Figure 21: Global Market Share (%) By Types (2032)

Figure 22: Global Point-of-care Ultrasound (PoCUS) Device Market Value (USD Million) By Region

Figure 23: Global Point-of-care Ultrasound (PoCUS) Device Market Share (%) By: Regions (2032)

Figure 24: Data Triangulation

List of Tables

77 items

Table 1: Market Segmentation Analysis

Table 2: Global Point-of-care Ultrasound (PoCUS) Device Revenue (USD Million) And Cagr (%) By Application (2020-2032)

Table 3: Global Point-of-care Ultrasound (PoCUS) Device Revenue (USD Million) And Cagr (%) By Types (2020-2032)

Table 4: Global Point-of-care Ultrasound (PoCUS) Device Revenue (USD Million) And Cagr (%) By Region (2020-2032)

Table 5: Global Market Value (USD Million) (2020-2024) By Application

Table 6: Global Market Share (%) By Application (2024)

Table 7: Global Market Value (USD Million) (2020-2024) By Types

Table 8: Global Market Share (%) By Types (2024)

Table 9: Global Point-of-care Ultrasound (PoCUS) Device Market Value (USD Million) By Region

Table 10: Global Point-of-care Ultrasound (PoCUS) Device Market Share (%) By Region

Table 11: North America Market Value (USD Million) (2020-2024) By Country

Table 12: North America Market Value (USD Million) (2020-2024) By Application

Table 13: North America Market Value (USD Million) (2020-2024) By Types

Table 14: Europe Market Value (USD Million) (2020-2024) By Country

Table 15: Europe Market Value (USD Million) (2020-2024) By Application

Table 16: Europe Market Value (USD Million) (2020-2024) By Types

Table 17: Asia Pacific Market Value (USD Million) (2020-2024) By Country

Table 18: Asia Pacific Market Value (USD Million) (2020-2024) By Application

Table 19: Asia Pacific Market Value (USD Million) (2020-2024) By Types

Table 20: South America Market Value (USD Million) (2020-2024) By Country

Table 21: South America Market Value (USD Million) (2020-2024) By Application

Table 22: South America Market Value (USD Million) (2020-2024) By Types

Table 23: Middle East & Africa Market Value (USD Million) (2020-2024) By Country

Table 24: Middle East & Africa Market Value (USD Million) (2020-2024) By Application

Table 25: Middle East & Africa Market Value (USD Million) (2020-2024) By Types

Table 26: Global Point-of-care Ultrasound (PoCUS) Device Market Revenue (USD Million) And Market Share (%) Of Key Manufacturers (2024)

Table 27: Global Point-of-care Ultrasound (PoCUS) Device Market: Profiled Players Head Office And Area Served

Table 28: Key Players Global Point-of-care Ultrasound (PoCUS) Device Market:

Table 29: Mergers & Acquisitions, Expansion Plans

Table 30: Fujifilm Holdings Corporation Basic Information And Sales Area

Table 31: Fujifilm Holdings Corporation. Products Portfolio

Table 32: Samsung Electronics Co. Ltd. Basic Information And Sales Area

Table 33: Samsung Electronics Co. Ltd.. Products Portfolio

Table 34: Koninklijke Philips N.V. Basic Information And Sales Area

Table 35: Koninklijke Philips N.V.. Products Portfolio

Table 36: Canon Medical Systems Corporation Basic Information And Sales Area

Table 37: Canon Medical Systems Corporation. Products Portfolio

Table 38: Hologic Inc. Basic Information And Sales Area

Table 39: Hologic Inc.. Products Portfolio

Table 40: GE Basic Information And Sales Area

Table 41: GE. Products Portfolio

Table 42: Alpinion Medical Systems Co. Ltd. Basic Information And Sales Area

Table 43: Alpinion Medical Systems Co. Ltd.. Products Portfolio

Table 44: Esaote S.p.A. Basic Information And Sales Area

Table 45: Esaote S.p.A.. Products Portfolio

Table 46: Shenzhen Mindray Bio-Medical Electronics Co. Ltd. Basic Information And Sales Area

Table 47: Shenzhen Mindray Bio-Medical Electronics Co. Ltd.. Products Portfolio

Table 48: BK Medical Holding Company Inc. Basic Information And Sales Area

Table 49: BK Medical Holding Company Inc.. Products Portfolio

Table 50: Hitachi Ltd. Basic Information And Sales Area

Table 51: Hitachi Ltd.. Products Portfolio

Table 52: Siemens AG Basic Information And Sales Area

Table 53: Siemens AG. Products Portfolio

Table 54: Global Market Value (USD Million) (2025-2032) By Application

Table 55: Global Market Share (%) By Application (2032)

Table 56: Global Market Value (USD Million) (2025-2032) By Types

Table 57: Global Market Share (%) By Types (2032)

Table 58: Global Point-of-care Ultrasound (PoCUS) Device Market Value (USD Million) By Region

Table 59: Global Point-of-care Ultrasound (PoCUS) Device Market Share (%) By Region (2025-2032)

Table 60: North America Market Value (USD Million) (2025-2032) By Country

Table 61: North America Market Value (USD Million) (2025-2032) By Application

Table 62: North America Market Value (USD Million) (2025-2032) By Types

Table 63: Europe Market Value (USD Million) (2025-2032) By Country

Table 64: Europe Market Value (USD Million) (2025-2032) By Application

Table 65: Europe Market Value (USD Million) (2025-2032) By Types

Table 66: Asia Pacific Market Value (USD Million) (2025-2032) By Country

Table 67: Asia Pacific Market Value (USD Million) (2025-2032) By Application

Table 68: Asia Pacific Market Value (USD Million) (2025-2032) By Types

Table 69: South America Market Value (USD Million) (2025-2032) By Country

Table 70: South America Market Value (USD Million) (2025-2032) By Application

Table 71: South America Market Value (USD Million) (2025-2032) By Types

Table 72: Middle East & Africa Market Value (USD Million) (2025-2032) By Country

Table 73: Middle East & Africa Market Value (USD Million) (2025-2032) By Application

Table 74: Middle East & Africa Market Value (USD Million) (2025-2032) By Types

Table 75: Research Programs/Design For This Report

Table 76: Key Data Information From Secondary Sources

Table 77: Key Data Information From Primary Sources

FAQs

1. What is the current Point-of-care Ultrasound (PoCUS) Device market size?

Global Point-of-care Ultrasound (PoCUS) Device market size surpassed USD 3.1 billion in 2023, propelled by bedside adoption across emergency, critical-care, and primary-care settings.

2. How fast is the PoCUS market expected to grow?

Analysts forecast a robust 7.8% CAGR through 2030, elevating the future outlook to approximately USD 5.2 billion as portable systems replace traditional cart-based units.

3. What are the key drivers behind PoCUS expansion?

Rising chronic disease burden, demand for rapid bedside diagnosis, lower device costs, and reimbursement favoring outpatient settings collectively accelerate Point-of-care Ultrasound (PoCUS) Device market size growth.

4. Which challenges could restrain future outlook?

Training shortages, variable image quality, fragmented reimbursement codes, and stringent infection-control protocols in ICUs pose near-term hurdles to sustained double-digit adoption.

5. Which region leads the PoCUS device market?

North America commands 41% share, driven by high ER volumes, favorable CPT codes, and strong R&D pipelines, while Asia-Pacific shows the fastest future outlook at 9% CAGR.

6. Who are the top companies shaping competitive dynamics?

GE HealthCare, Philips, Siemens Healthineers, Fujifilm SonoSite, and Butterfly Network lead through handheld silicon-chip probes, AI-enhanced workflows, and expansive post-sales education ecosystems.

7. Where lie the biggest future opportunities?

AI-embedded handheld probes for rural telehealth, muscle-skeletal sports clinics, veterinary practices, and emerging markets where price-sensitive analog systems still dominate present high-growth white space.

8. How is technology impacting PoCUS adoption?

Cloud-based AI assistants, single-cable whole-body probes, and app-based reporting slash learning curves, shorten exam times, and widen the future outlook beyond traditional radiology departments.

9. What is the current regulatory landscape for PoCUS devices?

FDA 510(k) clearances emphasize safety benchmarks, while EU MDR requires post-market clinical follow-up; both bodies increasingly accept real-world AI evidence, expediting new probe launches.

10. How do training and certification affect market penetration?

Hospitals cite credentialing bottlenecks as top barrier; vendors now bundle virtual simulation and competency-tracking platforms, accelerating user confidence and boosting Point-of-care Ultrasound (PoCUS) Device market size.

Contact for Full Report

Loading report content...

Market Snapshot

Loading chart…

Point-of-care Ultrasound (PoCUS) Device Market Overview

Loading chart…

Report Overview

Report Attribute	Details
Market size value in 2025	2.80 million
Revenue forecast in 2033	4.60 million
Growth rate	CAGR of 6.4% from 2025 to 2033
Actual data	2021 - 2024
Forecast period	2025 - 2033
Quantitative units	Revenue in USD Million and CAGR from 2025 to 2033
Report coverage	Revenue forecast, company share, competitive landscape, growth factors, and trends
Segments covered	Application, Types
Regional scope	North America; South America; Europe; Middle East & Africa; Asia Pacific
Country scope	United States; Canada; Mexico; Brazil; Argentina; Rest of South America; United Kingdom; Germany; France; Italy; Spain; Russia; Benelux; Nordics; Rest of Europe; Turkey; Israel; GCC; North Africa; South Africa; Rest of Middle East & Africa; China; India; Japan; South Korea; ASEAN; Oceania; Rest of Asia Pacific
Key companies profiled	Fujifilm Holdings Corporation; Samsung Electronics Co. Ltd.; Koninklijke Philips N.V.; Canon Medical Systems Corporation; Hologic Inc.; GE; Alpinion Medical Systems Co. Ltd.; Esaote S.p.A.; Shenzhen Mindray Bio-Medical Electronics Co. Ltd.; BK Medical Holding Company Inc.; Hitachi Ltd.; Siemens AG
Customization scope	Free report customization (equivalent to 8 analysts working days) with purchase. Addition or alteration to country, regional & segment scope.
Pricing and purchase options	Avail customized purchase options to meet your exact research needs. Explore purchase options